Indonesia vs Thailand: The number of people with susceptibility test result for rifampicin
Indonesia
72.55
in 2021
Thailand
76.11
in 2021
Indonesia rank
102nd
Thailand rank
99th
The number of people with susceptibility test result for rifampicin over time
- Indonesia
- Thailand
How they compare
Thailand currently reports 76.11 against 72.55 in Indonesia, a difference of 3.56.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Thailand ahead.
Indonesia ranks 102nd and Thailand ranks 99th of 146 countries.
Thailand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | Thailand | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 30.84 | 46.99 | 16.16 | Thailand |
| 2020s | 65.06 | 73.78 | 8.72 | Thailand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Indonesia or Thailand?
- Thailand, at 76.11 against 72.55 in Indonesia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Indonesia and Thailand?
- 3.56, with Thailand ahead.
- How many years of comparable data are there for Indonesia and Thailand?
- 5 years are reported by both, from 2017 to 2021.
- How do Indonesia and Thailand rank globally for the number of people with susceptibility test result for rifampicin?
- Indonesia ranks 102nd and Thailand ranks 99th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.